4.7 Article

Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study

Journal

BRAIN
Volume 139, Issue -, Pages 1472-1481

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/brain/aww037

Keywords

multiple sclerosis; 7 Tesla MRI; cortical lesions; subpial demyelination; ultrahigh field MRI; histopathology

Funding

  1. Dutch MS Research Foundation [09-358b]
  2. Dutch MS Research Foundation (EU-FP7)
  3. Noaber Foundation (Lunteren, The Netherlands)

Ask authors/readers for more resources

A substantialsproportion of multiple sclerosis cortical lesions go undetected with standard field (3T) MRI. Kilsdonk et al. compare the sensitivities of 7T versus 3T multi-contrast MRI protocols by validating them against histopathology in 19 patients and 4 controls. Ultra-high field 7T MRI more than doubles lesion detection.A substantialsproportion of multiple sclerosis cortical lesions go undetected with standard field (3T) MRI. Kilsdonk et al. compare the sensitivities of 7T versus 3T multi-contrast MRI protocols by validating them against histopathology in 19 patients and 4 controls. Ultra-high field 7T MRI more than doubles lesion detection.The relevance of cortical grey matter pathology in multiple sclerosis has become increasingly recognized over the past decade. Unfortunately, a large part of cortical lesions remain undetected on magnetic resonance imaging using standard field strength. In vivo studies have shown improved detection by using higher magnetic field strengths up to 7 T. So far, a systematic histopathological verification of ultra-high field magnetic resonance imaging pulse sequences has been lacking. The aim of this study was to determine the sensitivity of 7 T versus 3 T magnetic resonance imaging pulse sequences for the detection of cortical multiple sclerosis lesions by directly comparing them to histopathology. We obtained hemispheric coronally cut brain sections of 19 patients with multiple sclerosis and four control subjects after rapid autopsy and formalin fixation, and scanned them using 3 T and 7 T magnetic resonance imaging systems. Pulse sequences included T-1-weighted, T-2-weighted, fluid attenuated inversion recovery, double inversion recovery and T-2*. Cortical lesions (type I-IV) were scored on all sequences by an experienced rater blinded to histopathology and clinical data. Staining was performed with antibodies against proteolipid protein and scored by a second reader blinded to magnetic resonance imaging and clinical data. Subsequently, magnetic resonance imaging images were matched to histopathology and sensitivity of pulse sequences was calculated. Additionally, a second unblinded (retrospective) scoring of magnetic resonance images was performed. Regardless of pulse sequence, 7 T magnetic resonance imaging detected more cortical lesions than 3 T. Fluid attenuated inversion recovery (7 T) detected 225% more cortical lesions than 3 T fluid attenuated inversion recovery (Z = 2.22, P < 0.05) and 7 T T-2* detected 200% more cortical lesions than 3 T T-2* (Z = 2.05, P < 0.05). Sensitivity of 7 T magnetic resonance imaging was influenced by cortical lesion type: 100% for type I (T-2), 11% for type II (FLAIR/T-2), 32% for type III (T-2*), and 68% for type IV (T-2). We conclude that ultra-high field 7 T magnetic resonance imaging more than doubles detection of cortical multiple sclerosis lesions, compared to 3 T magnetic resonance imaging. Unfortunately, (subpial) cortical pathology remains more extensive than 7 T magnetic resonance imaging can reveal.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study

Philipp Vollmuth, Martha Foltyn, Raymond Y. Huang, Norbert Galldiks, Jens Petersen, Fabian Isensee, Martin J. van den Bent, Frederik Barkhof, Ji Eun Park, Yae Won Park, Sung Soo Ahn, Gianluca Brugnara, Hagen Meredig, Rajan Jain, Marion Smits, Whitney B. Pope, Klaus Maier-Hein, Michael Weller, Patrick Y. Wen, Wolfgang Wick, Martin Bendszus

Summary: This study aimed to assess the reproducibility and standardization of treatment response assessment using artificial intelligence (AI) decision support in MRI. The results showed that AI decision support can provide better evaluation of treatment response in patients with lower-grade gliomas compared to manual measurements.

NEURO-ONCOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals

Jarith L. Ebenau, Denise Visser, Sander C. J. Verfaillie, Tessa Timmers, Mardou S. S. A. van Leeuwenstijn, Mara ten Kate, Albert D. Windhorst, Frederik Barkhof, Philip Scheltens, Niels D. Prins, Ronald Boellaard, Wiesje M. van der Flier, Bart N. M. van Berckel

Summary: This study investigated the associations between cerebral blood flow (CBF), amyloid burden, and cognition in cognitively normal individuals with subjective cognitive decline (SCD). The results suggest that amyloid accumulation and decrease in rCBF are two parallel disease processes without a fixed order, and both provide unique predictive information for cognitive decline, with each process enhancing the other longitudinally.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Article Clinical Neurology

Brain age gap in neuromyelitis optica spectrum disorders and multiple sclerosis

Ren Wei, Xiaolu Xu, Yunyun Duan, Ningnannan Zhang, Jie Sun, Haiqing Li, Yuxin Li, Yongmei Li, Chun Zeng, Xuemei Han, Fuqing Zhou, Muhua Huang, Runzhi Li, Zhizheng Zhuo, Frederik Barkhof, James H. Cole, Yaou Liu

Summary: This study evaluated the clinical significance of deep learning-derived brain age prediction in NMOSD and RRMS. The results showed that both NMOSD and RRMS patients had a significantly higher brain age gap compared to healthy controls. The brain age gap was associated with baseline disability score, advanced brain volume loss, and disease duration. Additionally, the brain age gap predicted the worsening of disability status in both NMOSD and RRMS patients.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Clinical Neurology

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging

Rosa Cortese, Ferran Prados Carrasco, Carmen Tur, Alessia Bianchi, Wallace Brownlee, Floriana De Angelis, Isabel de la Paz, Francesco Grussu, Lukas Haider, Anu Jacob, Baris Kanber, Lise Magnollay, Richard S. Nicholas, Anand Trip, Marios Yiannakas, Ahmed T. Toosy, Yael Hacohen, Frederik Barkhof, Olga Ciccarelli

Summary: This study investigated whether imaging characteristics could differentiate between relapsing-remitting multiple sclerosis (RRMS), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). The results showed that the proportion of lesions with the central vein sign (CVS) was the most accurate measure to differentiate RRMS from AQP4-NMOSD, while white matter lesions were the most accurate measure to discriminate RRMS from MOGAD.

NEUROLOGY (2023)

Review Clinical Neurology

Interpretable machine learning for dementia: A systematic review

Sophie A. Martin, Florence J. Townend, Frederik Barkhof, James H. Cole

Summary: Machine learning research for automated dementia diagnosis is growing in popularity, but its clinical impact has been limited so far. The challenge lies in developing robust and generalizable models that can provide reliable explanations for their decisions. Some models are inherently interpretable, while post hoc explainability methods can be used for other models.

ALZHEIMERS & DEMENTIA (2023)

Letter Clinical Neurology

MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill? Reply

P. M. Cogswell, C. R. Jack Jr, J. A. Barakos, F. Barkhof, T. S. Benzinger, C. A. Raji, T. Y. Poussaint, V. K. Ramanan, C. T. Whitlow

AMERICAN JOURNAL OF NEURORADIOLOGY (2023)

Article Clinical Neurology

Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis

Alberto Calvi, Margareta A. Clarke, Ferran Prados, Declan Chard, Olga Ciccarelli, Manel Alberich, Deborah Pareto, Marta Rodriguez Barranco, Jaume Sastre-Garriga, Carmen Tur, Alex Rovira, Frederik Barkhof

Summary: This study found that chronic active lesions in magnetic resonance imaging (MRI), known as slowly expanding lesions (SELs) and paramagnetic rim lesions (PRLs), are associated with greater clinical progression in multiple sclerosis (MS) patients. SELs are more numerous than PRLs in MS patients.

MULTIPLE SCLEROSIS JOURNAL (2023)

Editorial Material Clinical Neurology

Otto van Eikema Hommes-7 February 1932-16 August 2022

Ludwig Kappos, Frederik Barkhof, Bernard Uitdehaag

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Computer Science, Interdisciplinary Applications

NiftyPAD-Novel Python Package for Quantitative Analysis of Dynamic PET Data

Jieqing Jiao, Fiona Heeman, Rachael Dixon, Catriona Wimberley, Isadora Lopes Alves, Juan Domingo Gispert, Adriaan A. Lammertsma, Bart N. M. van Berckel, Casper da Costa-Luis, Pawel Markiewicz, David M. Cash, M. Jorge Cardoso, Sebastien Ourselin, Maqsood Yaqub, Frederik Barkhof

Summary: This paper introduces a Python-based software package called NiftyPAD for versatile analyses of dynamic PET data. NiftyPAD can handle dual-time window scans, pharmacokinetic modelling, and PET data-based motion correction. It produces comparable results with established software packages and has the advantages of multi-platform usage, modular setup, and lightweight.

NEUROINFORMATICS (2023)

Review Clinical Neurology

Commercial volumetric MRI reporting tools in multiple sclerosis: a systematic review of the evidence

Zoe Mendelsohn, Hugh G. Pemberton, James Gray, Olivia Goodkin, Ferran Prados Carrasco, Michael Scheel, Jawed Nawabi, Frederik Barkhof

Summary: This article provides a systematic review of commercial QReports for multiple sclerosis (MS), highlighting limited evidence regarding clinical validation and in-use evaluation, particularly the lack of clinician end-user testing. The review aims to provide clinicians and institutions with the available evidence when considering adopting a quantitative reporting tool for MS.

NEURORADIOLOGY (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Advanced MR Techniques for Preoperative Glioma Characterization: Part 2

Gilbert Hangel, Barbara Schmitz-Abecassis, Nico Sollmann, Joana Pinto, Fatemehsadat Arzanforoosh, Frederik Barkhof, Thomas Booth, Marta Calvo-Imirizaldu, Guilherme Cassia, Marek Chmelik, Patricia Clement, Ece Ercan, Maria A. Fernandez-Seara, Julia Furtner, Elies Fuster-Garcia, Matthew Grech-Sollars, N. Tugay Guven, Gokce Hale Hatay, Golestan Karami, Vera C. Keil, Mina Kim, Johan A. F. Koekkoek, Simran Kukran, Laura Mancini, Ruben Emanuel Nechifor, Alpay Ozcan, Esin Ozturk-Isik, Senol Piskin, Kathleen M. Schmainda, Siri F. Svensson, Chih-Hsien Tseng, Saritha Unnikrishnan, Frans Vos, Esther Warnert, Moss Y. Zhao, Radim Jancalek, Teresa Nunes, Lydiane Hirschler, Marion Smits, Jan Petr, Kyrre E. Emblem

Summary: Preoperative clinical MRI protocols for gliomas still rely on conventional structural MRI, which does not provide information on tumor genotype and has limitations in the delineation of diffuse gliomas. The GliMR COST action aims to raise awareness about advanced MRI techniques in gliomas and their potential clinical translation. This review summarizes current methods, limitations, and applications of advanced MRI for the preoperative assessment of glioma, and evaluates the level of clinical validation of different techniques.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Advanced MR Techniques for Preoperative Glioma Characterization: Part 1

Lydiane Hirschler, Nico Sollmann, Barbara Schmitz-Abecassis, Joana Pinto, Fatemehsadat Arzanforoosh, Frederik Barkhof, Thomas Booth, Marta Calvo-Imirizaldu, Guilherme Cassia, Marek Chmelik, Patricia Clement, Ece Ercan, Maria A. Fernandez-Seara, Julia Furtner, Elies Fuster-Garcia, Matthew Grech-Sollars, Nazmiye Tugay Guven, Gokce Hale Hatay, Golestan Karami, Vera C. Keil, Mina Kim, Johan A. F. Koekkoek, Simran Kukran, Laura Mancini, Ruben Emanuel Nechifor, Alpay Oezcan, Esin Ozturk-Isik, Senol Piskin, Kathleen Schmainda, Siri F. Svensson, Chih-Hsien Tseng, Saritha Unnikrishnan, Frans Vos, Esther Warnert, Moss Y. Zhao, Radim Jancalek, Teresa Nunes, Kyrre E. Emblem, Marion Smits, Jan Petr, Gilbert Hangel

Summary: This article introduces the preoperative clinical magnetic resonance imaging (MRI) protocols for gliomas, which still rely on conventional structural MRI. However, this method lacks information on tumor genotype and has limitations in delineating diffuse gliomas. The GliMR COST action aims to raise awareness and discuss the clinical translation of advanced MRI techniques for gliomas.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Article Oncology

The patients' experience of neuroimaging of primary brain tumors: a cross-sectional survey study

Ivar J. H. G. Wamelink, Hugo L. L. Hempel, Elsmarieke van de Giessen, Mark H. M. Vries, Philip De Witt Hamer, Frederik Barkhof, Vera C. C. Keil

Summary: This study aims to understand the experiences of patients with primary brain tumors regarding MRI, follow-up protocols, and the use of gadolinium-based contrast agents (GBCAs). The analysis of patient surveys revealed that patients consistently underestimated the number of previous scans and most patients did not find MRI bothersome and would not change the frequency of follow-up MRIs. Women were found to be more uncomfortable with the MRI and receiving intravenous cannulas. Patient knowledge of GBCAs was limited.

JOURNAL OF NEURO-ONCOLOGY (2023)

Article Clinical Neurology

Prognostic value of single-subject grey matter networks in early multiple sclerosis

Vinzenz Fleischer, Gabriel Gonzalez-Escamilla, Deborah Pareto, Alex Rovira, Jaume Sastre-Garriga, Piotr Sowa, Einar A. Hogestol, Hanne F. Harbo, Barbara Bellenberg, Carsten Lukas, Serena Ruggieri, Claudio Gasperini, Tomas Uher, Manuela Vaneckova, Stefan Bittner, Ahmed E. Othman, Sara Collorone, Ahmed T. Toosy, Sven G. Meuth, Frauke Zipp, Frederik Barkhof, Olga Ciccarelli, Sergiu Groppa

Summary: This study investigated the prognostic value of longitudinal structural networks in predicting 5-year Expanded Disability Status Scale (EDSS) progression in relapsing-remitting multiple sclerosis (RRMS) patients. The study found that changes in network degree and global efficiency can predict disability accumulation independent of disease activity, and these network measures outperform conventional MRI predictors in predicting EDSS worsening.

BRAIN (2023)

Article Genetics & Heredity

Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning

Alexander Neumann, Olena Ohlei, Fahri Kucukali, Isabelle J. Bos, Jigyasha Timsina, Stephanie Vos, Dmitry Prokopenko, Betty M. Tijms, Ulf Andreasson, Kaj Blennow, Rik Vandenberghe, Philip Scheltens, Charlotte E. Teunissen, Sebastiaan Engelborghs, Giovanni B. Frisoni, Oliver Blin, Jill C. Richardson, Regis Bordet, Alberto Lleo, Daniel Alcolea, Julius Popp, Thomas W. Marsh, Priyanka Gorijala, Christopher Clark, Gwendoline Peyratout, Pablo Martinez-Lage, Mikel Tainta, Richard J. B. Dobson, Cristina Legido-Quigley, Christine Van Broeckhoven, Rudolph E. Tanzi, Mara ten Kate, Christina M. Lill, Frederik Barkhof, Carlos Cruchaga, Simon Lovestone, Johannes Streffer, Henrik Zetterberg, Pieter Jelle Visser, Kristel Sleegers, Lars Bertram

Summary: This study identified five genetic loci associated with cerebrospinal fluid (CSF) biomarker profiles related to Alzheimer's disease (AD), two of which were newly discovered. The study also found seven loci that showed sex-specific associations with AD biomarkers. Mediation tests revealed that variants in APOE are associated with AD status through processes related to amyloid and tau pathology, while markers in TMEM106B and CHI3L1 are associated with AD only through neuronal injury/inflammation.

GENOME MEDICINE (2023)

No Data Available